scispace - formally typeset
C

Christopher D. Askew

Researcher at University of the Sunshine Coast

Publications -  137
Citations -  3271

Christopher D. Askew is an academic researcher from University of the Sunshine Coast. The author has contributed to research in topics: Intermittent claudication & Claudication. The author has an hindex of 30, co-authored 126 publications receiving 2557 citations. Previous affiliations of Christopher D. Askew include National Health and Medical Research Council & University of Queensland.

Papers
More filters
Journal ArticleDOI

Skeletal muscle phenotype is associated with exercise tolerance in patients with peripheral arterial disease

TL;DR: In this paper, the authors investigated the association between skeletal muscle and exercise intolerance in peripheral arterial disease (PAD), and found that muscle phenotype is altered in PAD compared with control subjects and that exercise tolerance in patients PAD would be related to muscle phenotype.

Effect of cold water immersion on repeated cycling performance and limb blood flow

TL;DR: It is indicated that CWI is an effective intervention for maintaining repeat cycling performance in the heat and this performance benefit is associated with alterations in core temperature and limb blood flow.
Journal ArticleDOI

EEG activity and mood in health orientated runners after different exercise intensities

TL;DR: Results showed an effect for the preferred and high intensity velocity in both, EEG and mood, and it was concluded that this might be a sign of outlasting effects of exercise on brain cortical activity which may have influences on general well-being.
Journal ArticleDOI

Effect of Ramipril on Walking Times and Quality of Life Among Patients With Peripheral Artery Disease and Intermittent Claudication: A Randomized Controlled Trial

TL;DR: Among patients with intermittent claudication, 24-week treatment with ramipril resulted in significant increases in pain-free and maximum treadmill walking times compared with placebo, and was associated with a significant increase in the physical functioning component of the SF-36 score.